Delivery Order SPE2DB24D2205-SPE2DB25FDXAA

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.25 firm fixed-price delivery order is for the supply of Toviaz ER 8 mg tablets, a prescription medication, to support military healthcare programs. The contract has a performance period through May 5, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,636.56 firm fixed-price delivery order is for the medication TOVIAZ ER 4 MG TABLET 30S. The contract has a completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a $1,877.94 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Toviaz ER 4 mg tablets, a medication used to treat overactive bladder. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,598.85 firm fixed price delivery order is for the supply of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product, with a completion date of February 25, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,313.70, is for the supply of the medication TOVIAZ ER 8 MG TABLET 30S. The contract has a firm-fixed price pricing type and runs through May 31, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,763.99 firm-fixed-price delivery order is for the pharmaceutical product TOVIAZ ER 8 MG TABLET 30S. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as...
This federal contract award is a delivery order valued at $1,222.74 for the pharmaceutical product TOVIAZ ER 4 MG TABLET 30S. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 22, 2025 and is a firm fixed price arrangement. The contract does not have a set-aside designation, indicating it was competitively...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,778.94 firm-fixed-price delivery order is for the supply of TOVIAZ ER 8 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support...
This federal contract award to Amerisourcebergen Drug Corp, valued at $1,461.42, is for the delivery of the pharmaceutical product TOVIAZ ER 8 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this delivery order contract. The contract is a firm fixed-price arrangement with a completion date of July 11, 2024....
This federal contract award, valued at $1,688.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4559754687 TOVIAZ ER 8 MG TABLET 30S, with a completion date of January 30, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXAA
    Delivery Order

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,254.09, is for the supply of Toviaz ER 8 MG Tablet 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 4/18/25, 3:57 AM